The clinical features of rheumatoid arthritis
W Grassi, R De Angelis, G Lamanna… - European journal of …, 1998 - Elsevier
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by progressive
damage of synovial-lined joints and variable extra-articular manifestations. Tendon and …
damage of synovial-lined joints and variable extra-articular manifestations. Tendon and …
[HTML][HTML] Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis
…, AL Herrick, F Ingegnoli, N Damjanov, R De Angelis… - Autoimmunity …, 2020 - Elsevier
Capillaroscopy is a non-invasive and safe tool which allows the evaluation of the
morphology of the microcirculation. Since its recent incorporation in the 2013 American …
morphology of the microcirculation. Since its recent incorporation in the 2013 American …
Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
R De Angelis, M Sant, MP Coleman, S Francisci… - The lancet …, 2014 - thelancet.com
Background Cancer survival is a key measure of the effectiveness of health-care systems.
EUROCARE—the largest cooperative study of population-based cancer survival in Europe …
EUROCARE—the largest cooperative study of population-based cancer survival in Europe …
[HTML][HTML] Cancer survival in five continents: a worldwide population-based study (CONCORD)
…, M Quaresma, F Berrino, JM Lutz, R De Angelis… - The lancet …, 2008 - thelancet.com
Background Cancer survival varies widely between countries. The CONCORD study
provides survival estimates for 1· 9 million adults (aged 15–99 years) diagnosed with a first …
provides survival estimates for 1· 9 million adults (aged 15–99 years) diagnosed with a first …
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
…, C Allemani, C Tereanu, R De Angelis… - Blood, The Journal …, 2010 - ashpublications.org
Changing definitions and classifications of hematologic malignancies (HMs) complicate
incidence comparisons. HAEMACARE classified HMs into groupings consistent with the …
incidence comparisons. HAEMACARE classified HMs into groupings consistent with the …
[HTML][HTML] Measuring cancer prevalence in Europe: the EUROPREVAL project
R Capocaccia, M Colonna, I Corazziari, R De Angelis… - Annals of …, 2002 - Elsevier
Cancer prevalence is the proportion of individuals in a population who at some stage during
their lifetime have been diagnosed with cancer, irrespective of the date of diagnosis. Cancer …
their lifetime have been diagnosed with cancer, irrespective of the date of diagnosis. Cancer …
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study
F Berrino, R De Angelis, M Sant, S Rosso… - The lancet …, 2007 - thelancet.com
Background EUROCARE is the largest population-based cooperative study on survival of
patients with cancer. The EUROCARE project aims to regularly monitor, analyse, and …
patients with cancer. The EUROCARE project aims to regularly monitor, analyse, and …
[HTML][HTML] Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
…, A Trama, D Serraino, A Zucchetto, R De Angelis… - European journal of …, 2015 - Elsevier
Background Head and neck (H&N) cancers are a heterogeneous group of malignancies,
affecting various sites, with different prognoses. The aims of this study are to analyse …
affecting various sites, with different prognoses. The aims of this study are to analyse …
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study
…, L Botta, S Mallone, R De Angelis… - The Lancet …, 2017 - thelancet.com
Background Rare cancers pose challenges for diagnosis, treatments, and clinical decision
making. Information about rare cancers is scant. The RARECARE project defined rare …
making. Information about rare cancers is scant. The RARECARE project defined rare …
[HTML][HTML] Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study
…, A Trama, D Serraino, L Dal Maso, R De Angelis… - European journal of …, 2015 - Elsevier
Abstract Background Survival differences across Europe for patients with cancers of breast,
uterus, cervix, ovary, vagina and vulva have been documented by previous EUROCARE …
uterus, cervix, ovary, vagina and vulva have been documented by previous EUROCARE …